scPharmaceuticals Inc (SCPH)
4.74
-0.08
(-1.76%)
USD |
NASDAQ |
May 17, 16:00
scPharmaceuticals Cash from Investing (TTM): 42.28M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 42.28M |
| December 31, 2023 | 19.96M |
| September 30, 2023 | -49.49M |
| June 30, 2023 | -15.78M |
| March 31, 2023 | -26.07M |
| December 31, 2022 | -45.86M |
| September 30, 2022 | 1.634M |
| June 30, 2022 | 0.371M |
| March 31, 2022 | 6.635M |
| Date | Value |
|---|---|
| December 31, 2021 | 32.13M |
| September 30, 2021 | 64.33M |
| June 30, 2021 | 25.12M |
| March 31, 2021 | -20.76M |
| December 31, 2020 | -33.46M |
| September 30, 2020 | -70.16M |
| June 30, 2020 | -40.47M |
| March 31, 2020 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-70.16M
Minimum
Sep 2020
64.33M
Maximum
Sep 2021
-6.446M
Average
--
Median
Mar 2020
Cash from Investing (TTM) Benchmarks
| Anika Therapeutics Inc | -5.846M |
| Spero Therapeutics Inc | -- |
| electroCore Inc | -- |
| NovaBay Pharmaceuticals Inc | 1.062M |
| Palatin Technologies Inc | 9.41M |